Q2FY26 Earnings Preview - Pharma & Healthcare
We expect pharmaceutical companies under our coverage to deliver a steady performance in Q2FY26, with aggregate revenue rising by 7.4% YoY and 2.7%...
355 Views
Axis Top Picks for the month of October 2025
Relative Underperformance Provides an Opportunity to Add Equity for the Long Term: On a YTD basis, the Indian market has underperformed the US...
292 Views
Pharmaceuticals: IPM: steady 8% growth in Aug-25
As per IQVIA, IPM saw 8.1% YoY growth in Aug-25 (7.1%% YoY in Jul-25, 9% YoY in Q1FY26, and 8% in FY25) with 0.8% YoY decline in units.
243 Views
Axis Top Picks for the month of September 2025
Axis Top Picks Basket delivered a return of 16.2% in the last six months against the 10.4% returns posted by Nifty 50, outperforming the Nifty 50...
270 Views
Axis Intellect - Balanced
Stock investment endeavors to deliver consistent outperformance over the long term by making a diversified investment of ‘Winners
352 Views